Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deliberations of an International Panel of Experts on OCT Angiography Nomenclature of Neovascular Age-Related Macular Degeneration.
Mendonça LSM, Perrott-Reynolds R, Schwartz R, Madi HA, Cronbach N, Gendelman I, Muldrew A, Bannon F, Balaskas K, Gemmy Cheung CM, Fawzi A, Ferrara D, Freund KB, Fujimoto J, Munk MR, Querques G, Ribeiro R, Rosenfeld PJ, Sadda SR, Sahni J, Sarraf D, Spaide RF, Schmidt-Erfurth U, Souied E, Staurenghi G, Tadayoni R, Wang RK, Chakravarthy U, Waheed NK. Mendonça LSM, et al. Among authors: muldrew a. Ophthalmology. 2021 Jul;128(7):1109-1112. doi: 10.1016/j.ophtha.2020.12.022. Epub 2020 Dec 25. Ophthalmology. 2021. PMID: 33359557 Free article. Review. No abstract available.
Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study.
Jackson TL, Chakravarthy U, Slakter JS, Muldrew A, Shusterman EM, O'Shaughnessy D, Arnoldussen M, Gertner ME, Danielson L, Moshfeghi DM; INTREPID Study Group. Jackson TL, et al. Among authors: muldrew a. Ophthalmology. 2015 Jan;122(1):138-45. doi: 10.1016/j.ophtha.2014.07.043. Epub 2014 Sep 7. Ophthalmology. 2015. PMID: 25208859 Clinical Trial.
A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN).
Chakravarthy U, Harding SP, Rogers CA, Downes S, Lotery AJ, Dakin HA, Culliford L, Scott LJ, Nash RL, Taylor J, Muldrew A, Sahni J, Wordsworth S, Raftery J, Peto T, Reeves BC. Chakravarthy U, et al. Among authors: muldrew a. Health Technol Assess. 2015 Oct;19(78):1-298. doi: 10.3310/hta19780. Health Technol Assess. 2015. PMID: 26445075 Free PMC article. Clinical Trial.
The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease.
Taylor J, Scott LJ, Rogers CA, Muldrew A, O'Reilly D, Wordsworth S, Mills N, Hogg R, Violato M, Harding SP, Peto T, Townsend D, Chakravarthy U, Reeves BC. Taylor J, et al. Among authors: muldrew a. Eye (Lond). 2016 Jan;30(1):68-78. doi: 10.1038/eye.2015.170. Epub 2015 Oct 9. Eye (Lond). 2016. PMID: 26449197 Free PMC article.
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial.
Jackson TL, Desai R, Simpson A, Neffendorf JE, Petrarca R, Smith K, Wittes J, Lewis C, Membrey L, Haynes R, Costen M, Steel DH, Muldrew A, Chakravarthy U; Macular Epiretinal Brachytherapy versus Ranibizumab (Lucentis) Only Treatment (MERLOT) Study Group. Jackson TL, et al. Among authors: muldrew a. Ophthalmology. 2016 Jun;123(6):1287-96. doi: 10.1016/j.ophtha.2016.02.028. Epub 2016 Apr 13. Ophthalmology. 2016. PMID: 27086023 Free article. Clinical Trial.
27 results